• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗北部转诊中心新冠肺炎患者的弓形虫病及其症状严重程度

Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran.

作者信息

Geraili Ali, Badirzadeh Alireza, Sadeghi Maryam, Mousavi Seyed Mahmoud, Mousavi Parisa, Shahmoradi Zabihollah, Hosseini Sayed-Mohsen, Hejazi Seyed Hossein, Rafiei-Sefiddashti Raheleh

机构信息

Tehran, Iran Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences.

Isfahan, Iran Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences.

出版信息

J Parasit Dis. 2023 Mar;47(1):185-191. doi: 10.1007/s12639-022-01556-5. Epub 2022 Dec 11.

DOI:10.1007/s12639-022-01556-5
PMID:36532601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9741704/
Abstract

Toxoplasmosis has been categorized as one of the long-lasting protozoan parasitic infections. It affects almost one-third of the world's population. In recent years, several documented studies have elucidated that infected individuals have a remarkably higher incidence of distinct health problems and show various adverse effects. In the PCR-positive COVID-19 patients in Gonbad-e-Kavus, Kalaleh, and Minoodasht counties in the northern part of Iran from June 2021 to December 2021, we sought to investigate any potential relationships between the severity of COVID-19 symptoms and acute and latent toxoplasmosis caused by (). Whole blood samples of 161 COVID-19 patients with positive PCR. The samples were centrifuged to separate serum and screened for two important antibodies against (IgM and IgG) by using ELISA kits for human anti- IgM and IgG. Anti- IgM and IgG antibodies were detected in 8/161 (5.0%) and 42/161 (26.1%) COVID-19 patients, respectively. No significant relationships were found between IgM and IgG results with clinical signs, age, sex, contact with animals, comorbidities, and also the mortality rate of people with COVID-19. These findings showed that acute and latent toxoplasmosis infections are common among patients with COVID-19; however, no significant associations were found between toxoplasma infections and the symptoms of COVID-19. Therefore, toxoplasmosis is not considered a risk factor for COVID-19.

摘要

弓形虫病已被归类为长期存在的原生动物寄生虫感染之一。它影响着世界近三分之一的人口。近年来,多项有记录的研究表明,受感染个体出现明显健康问题的发生率显著更高,并表现出各种不良影响。在2021年6月至2021年12月期间伊朗北部贡巴德 - 卡武斯、卡拉莱和米努达斯ht县的PCR阳性COVID - 19患者中,我们试图调查COVID - 19症状的严重程度与由()引起的急性和潜伏性弓形虫病之间的任何潜在关系。对161名PCR阳性的COVID - 19患者的全血样本进行检测。将样本离心以分离血清,并使用人抗 - IgM和IgG的ELISA试剂盒筛查针对()的两种重要抗体(IgM和IgG)。在161名COVID - 19患者中,分别有8/161(5.0%)和42/161(26.1%)检测到抗 - IgM和抗 - IgG抗体。未发现抗 - IgM和IgG结果与临床体征、年龄、性别、与动物接触、合并症以及COVID - 19患者的死亡率之间存在显著关系。这些发现表明,急性和潜伏性弓形虫病感染在COVID - 19患者中很常见;然而,未发现弓形虫感染与COVID - 19症状之间存在显著关联。因此,弓形虫病不被认为是COVID - 19的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/9998815/09c6eb4997cc/12639_2022_1556_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/9998815/09c6eb4997cc/12639_2022_1556_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/9998815/09c6eb4997cc/12639_2022_1556_Fig1_HTML.jpg

相似文献

1
Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran.伊朗北部转诊中心新冠肺炎患者的弓形虫病及其症状严重程度
J Parasit Dis. 2023 Mar;47(1):185-191. doi: 10.1007/s12639-022-01556-5. Epub 2022 Dec 11.
2
Exploring the Association Between Latent Toxoplasma gondii Infection and COVID-19 in Hospitalized Patients: First Registry-Based Study.探讨潜伏性弓形虫感染与住院患者 COVID-19 之间的关联:首个基于注册的研究。
Acta Parasitol. 2022 Sep;67(3):1172-1179. doi: 10.1007/s11686-022-00559-9. Epub 2022 May 11.
3
Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV/AIDS Patients in Northern Iran.伊朗北部艾滋病毒/艾滋病患者弓形虫病的血清学评估及相关危险因素
Acta Parasitol. 2021 Dec;66(4):1417-1423. doi: 10.1007/s11686-021-00410-7. Epub 2021 May 22.
4
Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.埃塞俄比亚西北部巴赫达尔地区 HIV 感染和未感染个体弓形体病的血清流行率及危险因素。
Parasit Vectors. 2013 Jan 16;6(1):15. doi: 10.1186/1756-3305-6-15.
5
Seroepidemiological study of toxoplasmosis in women referred to a pre-marriage counseling center in Alborz Province, Iran.伊朗阿尔博兹省婚前咨询中心就诊妇女弓形虫病血清流行病学研究。
BMC Res Notes. 2021 Apr 30;14(1):163. doi: 10.1186/s13104-021-05581-0.
6
Seroprevalence of Toxoplasma gondii Infections in Pregnant Women in Gorgan City, Golestan Province, Northern Iran-2012.2012年伊朗北部戈勒斯坦省戈尔甘市孕妇弓形虫感染血清阳性率
Iran J Parasitol. 2014 Apr-Jun;9(2):181-7.
7
Sero-molecular evaluation of Toxoplasma gondii infection among HIV-positive patients.HIV 阳性患者弓形虫感染的血清分子评估。
Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):771-775. doi: 10.1093/trstmh/trz082.
8
Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran.伊朗东南部健康献血者中弓形虫感染的血清流行率及危险因素
Parasite Immunol. 2015 Jul;37(7):362-7. doi: 10.1111/pim.12198.
9
Prevalence of and Among Myositis Patients in the Southwest of Iran.伊朗西南部肌炎患者中抗合成酶抗体和抗黑色素瘤分化相关基因 5 抗体的流行率。
Infect Disord Drug Targets. 2021;21(1):43-48. doi: 10.2174/1871526520666191231123159.
10
Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.喀麦隆西北部Njinikom育龄妇女弓形虫IgG和IgM抗体血清阳性率及相关危险因素
BMC Res Notes. 2016 Aug 15;9(1):406. doi: 10.1186/s13104-016-2206-0.

引用本文的文献

1
Ocular Toxoplasmosis: Advances in Biology, Clinical Manifestations, Diagnostics, and Therapy.眼部弓形虫病:生物学、临床表现、诊断与治疗的进展
Pathogens. 2024 Oct 14;13(10):898. doi: 10.3390/pathogens13100898.
2
Frequency of exposure to Toxoplasma gondii in COVID-19 patients: a systematic review and meta-analysis.COVID-19 患者感染弓形虫的频率:系统评价和荟萃分析。
BMC Public Health. 2024 Oct 19;24(1):2885. doi: 10.1186/s12889-024-20334-x.
3
Sero-prevalence of Toxoplasma gondii before and during the COVID-19 pandemic in Northwestern Iran.
伊朗西北部 COVID-19 大流行前后弓形虫血清阳性率。
BMC Infect Dis. 2024 Aug 16;24(1):834. doi: 10.1186/s12879-024-09724-z.
4
Impact of latent toxoplasmosis on pneumonic and non-pneumonic COVID-19 patients with estimation of relevant oxidative stress biomarkers.潜伏性弓形体感染对有或无肺部表现的 COVID-19 患者的影响,并评估相关氧化应激生物标志物。
Folia Parasitol (Praha). 2024 Apr 4;71:2024.008. doi: 10.14411/fp.2024.008.
5
Genetic diversity and seroprevalence of Toxoplasma gondii in COVID‑19 patients; a first case-control study in Iran.COVID-19 患者弓形虫的遗传多样性和血清流行率;伊朗的首例病例对照研究。
BMC Infect Dis. 2024 Jan 3;24(1):42. doi: 10.1186/s12879-023-08964-9.
6
Clinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients.潜伏性弓形虫病对COVID-19患者的临床和免疫学影响。
Cureus. 2023 Sep 26;15(9):e45989. doi: 10.7759/cureus.45989. eCollection 2023 Sep.
7
Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional study.COVID-19 突破性感染与弓形虫感染的相关性:一项横断面研究。
Sci Rep. 2023 Oct 17;13(1):17636. doi: 10.1038/s41598-023-44616-3.
8
Co-infection of COVID-19 and parasitic diseases: A systematic review.新型冠状病毒肺炎与寄生虫病的合并感染:一项系统综述。
Parasite Epidemiol Control. 2023 May;21:e00299. doi: 10.1016/j.parepi.2023.e00299. Epub 2023 Mar 30.